OVERVIEW

Noetic Fund

A group of venture funds launched by Grey House Partners GP Inc. to invest in emerging and early-stage wellness, therapeutic and pharmaceutical companies around the globe. We have proudly taken the North Star pledge and believe in the importance of stewarding this sector in the right way.

About

noetic

“From the Greek noēsis/ noētikos meaning inner wisdom, direct knowing, or subjective understanding”

Noetic science refers to a multidisciplinary field that brings objective scientific tools and techniques together with subjective understanding to study the full range of human experience.

Our Mission

Our mission is to nurture the scientific advancement of mental, emotional, psychological and physical health by investing in alternative therapies, modalities, and sciences that are committed to optimizing our human experience.

Our Commitment

We are committed to the development of pure, innovative and sustainable products and services that utilize technological innovation and the power of bioavailable plants that are often psychedelic in nature to help define a healthy future for our people and our planet.

Our Focus

Psychedelic medicine and related sustainable solutions for mental health and physical well being.

Investment

Our Portfolio

Noetic Funds focus on finding teams with the skills, expertise, management experience, and governance structures in place to build world class companies.

Eve Health Systems

Eve Health Systems is a mental health services matching engine and practice management system, optimizing each piece of the experience for users seeking therapy.

GHP Noetic Science-Psychedelic Pharma Inc.

Capital Pool Corporation (CPC) formed to assist a future qualifying transaction to access the capital markets to fund its growth and expansion

Eve Health Systems

GHP Noetic Science-Psychedelic Pharma Inc.

Noetic Conscioiusness Inc

Meet The Team

Our Team

Michael MacLachlan Franks

Managing Partner

6 years in venture capital, Silicon Valley, with focus on technology and software

20 years in mid-market M&A / Private Equity – c suite – private/publics – with top decile returns of 10x to 40x

BA in Economics from Queen’s University, Kingston

MBA from Trinity College, Dublin.

Sa'ad Shah

Managing Partner

9 years at RBC Capital Markets in real estate banking, corporate credit, and derivative sales & trading

9 years at DGAM (acquired by The Carlyle Group) – Head of Marketing and Client Services, helped build AUM to $6.8B at peak

BA in Economics and Political Science from Columbia University.

Warren Wright - Noetic

Warren Wright

Managing Partner

9 years at Northwater Capital Management, as Managing Director – Head of Hedge Fund Investments

12 years at DGAM (acquired by The Carlyle Group) as Chief Investment Officer

Partner at The Carlyle Group and Chief Investment Officer of The Carlyle Liquid Markets Group.

Tim Piser - Noetic

Dr Tim Piser

Senior Advisor

Chief Scientific Officer of Noetic Foundry

25+ years of experience in neuroscience drug discovery and drug development

Former CSO of Cadent Therapeutics, acquired by Novartis in December 2020 for ~$800 million

Former Global Product Director at AstraZeneca, overseeing neuroscience drug development programs

Ph.D. in Pharmacology from University of Minnesota-Twin Cities and B.Sc. In Biology from University of Delaware

Richard Cheung

General Counsel

15+ years advising clients in the life sciences industry on intellectual property and regulatory matters at firms including Fasken, Ogilvy Renault (now Norton Rose Fulbright Canada), and Bereskin & Parr

Licensed pharmacist in the Province of Ontario with experience in community and hospital pharmacy

LL.B. from Western University

Ph.D. in Pharmaceutical Sciences (drug delivery) and B.Sc.Phm. (Pharmacy) from the University of Toronto

Registered Patent Agent and Trademark Agent in Canada

Craig-Hippern---Noetic

Craig Hippern

COO, CFO & CCO

25+ years in the onshore and offshore investment industry

10 years as CFO with a Bermuda-based hedge fund and a Canadian real estate development company

8.5 years at Northwater Capital Management, as VP of Finance & Risk Mgmt. and Hedge Fund Investment Due Diligence

CPA,CA (Canada) and CPA(IL) (U.S.A.)

Paul Barbeau

Chief Technology Officer

Led numerous complex enterprise projects across multiple sectors including government, legal, medical, private and public companies over the past 20+ years

Held C-Level roles in private and public companies

Developed and deployed Clinically Proven technology for Hospitals and Patients in Canada

Robust Data Security experience and numerous certifications

Top 40 under 40 in Ottawa

Vanessa Levi

Head of Europe, Business Development

9 years at Russell Investments – Head of Italy, helped build AUM to $8B and opened Milan office

6 years as Managing Partner of a single family office investing across all asset classes

6 years in healthcare research and consultancy at Datamonitor and Frost & Sullivan 

BA Hon in Business Administration from European Business School in London

Preetha Nooyi

VP Business Development

7 years working across innovation, consumer insights, and product development roles in the consumer packaged goods industry

Led teams and product pipelines at Estee Lauder Companies and Hain Celestial Group. Co-developed the investment thesis and strategic framework to screen potential CPG acquisitions and investments at Lindsay Goldberg

5 years of training and class facilitation in leadership development at Yale School of Management

MBA from Yale School of Management

BA in Geosciences from Hamilton College

Josh Hardman

Senior Associate

5+ years research experience, from start-up market research to informing $3bn+ government spending envelopes

Founder of Psilocybin Alpha, leading resource for analysis of the emergent psychedelic sector

Consultant on numerous projects employing disruptive tech to solve social issues

BSc Government, the London School of Economics; with a year at UC Berkeley

Sara Nahon

Associate

1 year in Science Policy and Capacity Building Division, UNESCO

M.Res. in Psychiatry seeking to validate cognitive biomarkers measuring decline and pharmacological intervention in Parkinson’s disease, Somerville College, University of Oxford

B.Sc. in. Anatomy and Cell Biology, McGill University.

Alyssa Segula

Management Associate

8+ years working with marginalized communities across a variety of acute and community settings, with a focus on community reintegration, consultation, education, psychiatric nursing assessment, and psychotherapy treatment 

Board Director at A Greener Future, an environmental non-profit organization located in Toronto 

MBA Candidate at Schulich School of Business

MSc in Mental Health Recovery and Social Inclusion, University of Hertfordshire; BSc Nursing, University of Western Ontario 

Daria Zhukova

Operations and Finance

3+ years of experience in business operations and office administration.

Managed financial accounting for multimillion-dollar corporations, including companies operating in medical and pharmaceutical industries.

BA in Economics and Mathematics from the University of British Columbia, with one year study at the National University of Singapore, focusing on financial markets and macroeconomics

Matthew Baggott, PhD

Venture Partner

CEO of Tactogen

30-year career spanning data science, preclinical pharmacology, clinical research, neuroscience, genomics and drug development

Bachelor’s degree in Philosophy and Post-doctoral Fellow at the University of Chicago

Ph.D. in Neuroscience from the University of California, Berkeley.

Jeffrey Becker - Noetic

Jeffrey Becker, MD

Venture Partner

CSO & Co-Founder of Bexson Biomedical, Inc.

Board-certified in Psychiatry and Integrative & Holistic Medicine

Leader in applied genetics and functional nutrient science in mental health

Ketamine assisted psychotherapy trainer and opinion leader

UC Berkeley Bachelor’s in Biology, Entomology & Religious Mysticism; UCLA Medical graduate & psychiatric resident

David Rabin, MD, PhD

Venture Partner

CIO of Apollo Neuroscience

Board-certified psychiatrist, neuroscientist, tech entrepreneur & inventor

Operates a clinical psychiatry practice and conducting research on the epigenetic regulation of trauma responses and recovery

Graduate degrees from Albany Medical College and psychiatric residency from Pittsburgh Medical Center.

Jonathan Alderson

Advisor

Specialist in curriculum design and multi-disciplinary models of therapy.

15 years Founder/ Director Integrative Multi-Treatment Autism Program. Innovated “Priming” and “Attitude Fitness” that accelerate learning and change.  

6 years Administrator and Senior Trainer Autism Treatment Centre of America, Massachusetts

Author, Challenging the Myths of Autism (Harper Collins, 2011)

Dip. French Literature, Sorbonne University, Paris

B.A. Hon Developmental and Educational Psychology, Western University

Ed.M. International Education Policy, Harvard University

Prof. Ede Frecska, PhD

Advisor

Chairman of Psychiatry at the Faculty of Medicine of the University of Debrecen

Residency training in Psychiatry both in Hungary (1986), and in the United States (1992)

Qualified psychopharmacologist (1987) of international merit

17 years of clinical and research experience in the United States.

Marci Freedman

Advisor

25+ years of lifestyle marketing experience with companies including Reebok and Vitaminwater.

8 years developing, executing and implementing national programs which helped define and build the Vitaminwater and Smartwater brands.

Advisory Board member of Cloud Water Brands, Gem&Bolt Mezcal and Prosper Technologies Holdings to name a few.

Adventurer, Explorer, and World Traveler.

Jody Levy

Advisor

Jody Levy is an artist, designer, director, entrepreneur, executive and investor.

Jody is the founder, creative director and Chief Executive Officer of a handful of companies dedicated to empowering people to be as healthy and happy as possible.

Luis Eduardo Luna, PhD

Advisor

Guggenheim Fellow (1986), Fellow of the Linnaean Society of London (1989), and Doctor Honoris Causa, from St. Lawrence, Canton, New York (2002)

Ph.D. from the Department of Comparative Religion Stockholm University (1989)

Master from Oslo University (1980)

B.A. from Madrid University (1972).

Victor Mifsud

Advisor

10+ years in the psychedelic/health optimization space. Founder of the Vision Optimization Summit.
 
Recently completed a feature-length documentary film called “My Neuroplastic Adventure“.
 
Worked/mentored with renowned national best-selling author and physician Dr. Gabor Maté, Dr. Lara Boyd, and Dr. Norman Doidge to name a few.
 
Ryerson University – New Media & Film 

Sri Teja Mullapudi, PhD

Advisor

Experienced in investment opportunity analysis in life sciences from TIAP (previously MaRS Innovation)

7+ years of research experience with 8 publications in peer-reviewed journals

Ph.D. (summa cum laude) in Biology from the Max Planck Society, Germany

M.Tech + B.Tech in Biotechnology (Minor in Chemistry) from Indian Institute of Technology Madras, India

Soccer player with Toronto City FC.

Naseem Saloojee

Advisor

6 years leading VC- and PE-backed growth businesses: SVP Sales at Top Hat (10X growth in 4 years) and CEO at Globalfaces Direct (100% growth in 2 years)

6 years as a consulting leader with McKinsey & Company, including a fellowship to McKinsey’s Social Sector Office

MBA from Harvard Business School

Subscribe

Subscribe to keep in touch and learn about the latest developments in the emerging psychedelic medicine space